文献速递生殖医学

新型磷脂酶C zeta 1突变与ICSI后受精失败相关

Novel phospholipase C zeta 1 mutations associated with fertilization failures after ICSI.
PubMed 文献 · Hum Reprod · 2019-01-01

该研究纳入2014至2018年间37例ICSI后完全或部分受精失败(受精率≤25%)患者,分为卵母细胞激活失败组(OAF,n=22)和其他原因失败组(no-OAF,n=15),并以13例受精良好(受精率>50%)男性为对照。OAF组中12例(54.6%)携带至少一个PLCZ1编码序列突变,no-OAF组1例(6.7%),对照组0例(P<0.05)。体外功能实验显示三个突变(p.R197H、p.H233L和p.V326K fs*25)显著降低卵母细胞激活率;携带PLCZ1突变的10例患者经辅助卵母细胞激活后受精率恢复至>60%,其中7例获得妊娠和活产。作者认为PLCZ1基因测序可能有助于OAF所致ICSI后受精失败夫妇的诊断和咨询。

要点

  • OAF组PLCZ1突变携带率54.6%(12/22),高于no-OAF组6.7%(1/15)和对照组0%(0/13),差异有统计学意义(P<0.05)。
  • 体外实验显示p.R197H、p.H233L和p.V326K fs*25三个突变显著降低卵母细胞激活百分比,提示对酶活性有有害影响。
  • 携带PLCZ1突变的10例患者经辅助卵母细胞激活后受精率恢复至>60%,其中7例获妊娠和活产。

核心结论

  • 新型PLCZ1序列突变与ICSI后受精失败相关。
  • 作者认为PLCZ1基因测序可能有助于OAF所致ICSI后受精失败夫妇的诊断和咨询。

研究设计与样本

  • 研究纳入2014至2018年间37例ICSI后完全或部分受精失败(受精率≤25%)患者,分为OAF组(n=22)和no-OAF组(n=15),并以13例受精良好(受精率>50%)男性为对照。
  • 采用免疫荧光和蛋白质印迹评估精子中PLCζ/PLCZ1蛋白定位和水平,Sanger测序检测PLCZ1外显子区突变,MODICT算法进行计算机模拟功能预测。
  • 将野生型和突变型PLCZ1 cRNA注射入人卵母细胞、体外成熟至中期II,注射后19小时评估第二极体排出和原核出现以判断受精结局。

主要发现

  • OAF组12例(54.6%)携带至少一个PLCZ1编码序列突变,no-OAF组1例(6.7%)(P<0.05),对照组0例(P<0.05)。
  • 共鉴定出六种不同突变,包括五种单核苷酸错义突变(p.I120M、p.R197H、p.L224P、p.H233L、p.S500L)和一种移码变异(p.V326K fs*25)。
  • MODICT计算机模拟预测除p.I120M外所有突变可能对PLCζ/PLCZ1活性有害。
  • PLCZ1 cRNA注射后,p.R197H、p.H233L和p.V326K fs*25三个突变显著降低卵母细胞激活百分比,提示对酶活性有有害影响。
  • 各组间精子PLCZ1蛋白定位和表达水平相似;携带PLCZ1突变的10例患者经辅助卵母细胞激活后受精率恢复至>60%,其中7例获得妊娠和活产。

临床怎么用

  • 作者认为PLCZ1基因测序可能有助于OAF所致ICSI后受精失败夫妇的诊断和咨询。

局限性

  • 将cRNA注射结果与ICSI后受精结局比较时应谨慎,尤其对于携带杂合突变的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are phospholipase C zeta 1 (PLCZ1) mutations associated with fertilization failure (FF) after ICSI? SUMMARY ANSWER: New mutations in the PLCZ1 sequence are associated with FFs after ICSI. WHAT IS KNOWN ALREADY: FF occurs in 1-3% of ICSI cycles, mainly due to oocyte activation failure (OAF). The sperm PLCζ/PLCZ1 protein hydrolyzes phosphatidylinositol (4, 5)-bisphosphate in the oocyte, leading to intracellular calcium release and oocyte activation. To date, few PLCZ1 point mutations causing decreased protein levels or activity have been linked to FF. However, functional alterations of PLCζ/PLCZ1 in response to both described and novel mutations have not been investigated. STUDY DESIGN, SIZE, DURATION: We performed a study including 37 patients presenting total or partial FF (fertilization rate (FR), ≤25%) after ICSI occurring between 2014 and 2018. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients were divided into two groups based on oocyte evaluation 19 h post ICSI: FF due to a defect in oocyte activation (OAF, n = 22) and FF due to other causes ('no-OAF', n = 15). Samples from 13 men with good fertilization (FR, >50%) were used as controls. PLCζ/PLCZ1 protein localization and levels in sperm were evaluated by immunofluorescence and western blot, respectively. Sanger sequencing on genomic DNA was used to identify PLCZ1 mutations in exonic regions. The effect of the mutations on protein functionality was predicted in silico using the MODICT algorithm. Functional assays were performed by cRNA injection of wild-type and mutated forms of PLCZ1 into human in vitro matured metaphase II oocytes, and fertilization outcomes (second polar body extrusion, pronucleus appearance) scored 19 h after injection. MAIN RESULTS AND THE ROLE OF CHANCE: In the OAF group, 12 (54.6%) patients carried at least one mutation in the PLCZ1 coding sequence, one patient out of 15 (6.7%) in the no-OAF group (P < 0.05) and none of the 13 controls (P < 0.05). A total of six different mutations were identified. Five of them were single-nucleotide missense mutations: p.I120M, located at the end of the EF-hand domain; p.R197H, p.L224P and p.H233L, located at the X catalytic domain; and p.S500 L, located at the C2 domain. The sixth mutation, a frameshift variant (p.V326K fs*25), generates a truncated protein at the X-Y linker region. In silico analysis with MODICT predicted all the mutations except p.I120M to be potentially deleterious for PLCζ/PLCZ1 activity. After PLCZ1 cRNA injection, a significant decrease in the percentage of activated oocytes was observed for three mutations (p.R197H, p.H233L and p.V326K fs*25), indicating a deleterious effect on enzymatic activity. PLCZ1 protein localization and expression levels in sperm were similar across groups. FRs were restored (to >60%) in patients carrying PLCZ1 mutations (n = 10) after assisted oocyte activation (AOA), with seven patients achieving pregnancy and live birth. LIMITATIONS, REASONS FOR CAUTION: Caution should be exerted when comparing the cRNA injection results with fertilization outcomes after ICSI, especially in patients presenting mutations in heterozygosis. WIDER IMPLICATIONS OF THE FINDINGS: PLCZ1 mutations were found in high frequency in patients presenting OAF. Functional analysis of three mutations in human oocytes confirms alteration of PLCζ/PLCZ1 activity and their likely involvement in impaired oocyte activation. Our results suggest that PLCZ1 gene sequencing could be useful as a tool for the diagnosis and counseling of couples presenting FF after ICSI due to OAF. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by intramural funding of Clínica EUGIN, by the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia (GENCAT 2015 DI 049 to M. T.-M. and GENCAT 2015 DI 048 to D. C.-B.) and by the Torres Quevedo Program from the Spanish Ministry of Economy and Competitiveness to A. F.-V. No competing interest declared.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Torra-Massana M, Cornet-Bartolomé D, Barragán M, et al. Novel phospholipase C zeta 1 mutations associated with fertilization failures after ICSI. Hum Reprod. 2019. PMID: 31347677. doi:10.1093/humrep/dez094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。